期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

帕金森病相关蛋白α-Synuclein翻译后修饰的研究 被引量：2

Post-translational modification of α-Synuclein in Parkinson Disease
下载PDF
导出
摘要 帕金森病是中老年常见的神经退行性疾病,以黑质多巴胺能神经元变性缺失和路易小体形成为特征。α-Synuclein是路易小体的主要组成成分,由于它在介导帕金森病的神经毒性方面发挥很大的作用,而越来越引起人们的关注。帕金森病相关蛋白α-Synuclein存在多种翻译后修饰,可能促使路易小体形成,从而参与帕金森病的发生和发展。本文在研究α-Synuclein蛋白的磷酸化、硝基化和泛素化与帕金森病的关系的基础上进行了总结。 Parkinson＇s disease is one of the most common neurodegenerative diseases among middle-aged people,characterized by progressive degeneration of dopaminergic neurons in the substantia nigra and accumulation of cytoplasmic inclusions termed Lewy bodies in surviving neurons.α-Synuclein,which is the main component of Lewy bodies,has raised more and more concerns about its function of mediating neurotoxicity in PD.Posttranslational modification（PTM） has been identified on α-Synuclein,which may promote Lewy body（LD） formation and play an important role in the initiation and progression of PD neuropathophysiology.We mainly discussed phosphorylation,nitrition and ubiquitination of α-Synuclein in this review.
作者 陈连连 曾照芳
机构地区 重庆医科大学检验系临床检验诊断学教育部重点实验室重庆市重点实验室
出处 《激光杂志》 CAS CSCD 北大核心 2010年第4期82-84,共3页 Laser Journal
关键词 帕金森病 蛋白质翻译后修饰 Α-共核蛋白 路易小体 磷酸化 硝基化 泛素化 Parkinson＇s disease Post-translational modifications α-Synuclein Lewy body phosphorylation nitrition ubiquitination
分类号 R477 [医药卫生—护理学]
  • 相关文献

参考文献32

  • 1Hubbard MJ, Cohen P. Trends Biochem Sci, 1993,18: 172- 177.
  • 2Mann M , Ong SE, Gronborg M, et al. Trends Biotechnol, 2002,20: 261 - 268.
  • 3Formman MS, Trojanowski JO, Lee VM. Neurodegenerative diseases: a decade of discoveries the way for therapeutic breakthroughs[J]. Nat Med, 2004,10 (10):1055- 1063.
  • 4Conway KA, Harper JD,Conway KA, Harper JD, Lansbury PT, et al. Biochemistry, 2000,39 : 2552 - 2563.
  • 5Volles, M., and Lansbury, P.J. Zeroing in on the pathogenic form of alpha- synuclein and its mechanism of ncurotoxicity in Parkinson' s disease[J]. Biochemistry, 2003,42:7871 - 7878.
  • 6Abeliovich, A., et al. Mice lacking alpha- synuclein display functional deficits in the nigrostriatal dopamine system[ J]. Neuron, 2000,25 : 239 - 252.
  • 7Nussbaum, R. L., and Polymeropoulos, M.H. Genetics of Parkinson' s disease[J].Hum. Mol. Genet, 1997,6:1687-1691.
  • 8Lee, V. M, and Trojanowski, J.Q. Mechanisms of Parkinson' s disease linked to pathological alpha - synuclein: new targets for drug discovery[J]. Neuron, 2006,52:33 - 38.
  • 9Fujiwara, H., Hasegawa, M., Dohmae, N. Kawashima, A. Masliah, E. Goldberg, M. S. Shen J., Takio K., Iwatsubo T, Alpha - Synuclein is phosphorylated in synucleinopathy lesions[ J]. Nat Cell Biol ,2002,4 (2): 160- 164.
  • 10Takahashi M, Ko LW, Kulathingal J, et al. Oxidative stress induced phosphorylation, degradation and aggregation of alpha- synuclein are linked to upregulated CK2 and cathepsin D [ J]. Eur J Neurosci, 2007,26(4) :863 - 874.

二级参考文献19

  • 1冯媛,梁直厚,王涛,乔娴,孙莉,刘红进,孙圣刚.鱼藤酮帕金森病大鼠模型建立的研究[J].卒中与神经疾病,2004,11(6):374-377. 被引量：20
  • 2Priyadarshi A,Khuder SA,Schaub EA,et al.Environmental risk factors and Parkinson's disease:a meta analysis[J].Environ Res,2001,86:122-127.
  • 3Amy B,Manning-Bog,Alison L,et al.The herbicide paraquat causes up-regulation and aggregation of alpha-synuclein in mice:paraquat and alpha-synuclein[J].J Biol Chem,2002,277:1641-1644.
  • 4Fornai F,Lenzi P,Gesi M,et al.Fine structure and biochemical mechanisms underlying nigrostriatal inclusions and cell death after proteasome inhibition[J].J Neurosci,2003,23:8955-8968.
  • 5Lehmensiek V,Tan EM,Schwarz J,et al.Expression of mutant α-synuclein enhances dopamine transport o e-mediated MPP^+ toxicity in vitro[J].Neurol Report,2002,13:1279-1283.
  • 6Sherer TB,Betarbet R,Testa CM,et al.Mechanism of toxicity in rotenone models of Parkinson's disease[J].J Neurosci,2003,23(34):10756-10764.
  • 7Cormier A,Morin C,Zini R,et al.Nicotine protects rat brain mitochondria against experimental injuries[J].Neuropharmacology,2003,44:642-652.
  • 8Hashimoto M,Hsu LJ,Rockenstein E,et al.alpha-Synuclein protects against oxidative stress via inactivation of the c-Jun N-terminal kinase stress-signaling pathway in neuronal cells[J].J Biochem,2002,277(13):11465-11472.
  • 9Burke WJ,Li SW,Chung HD,et al.Neurotoxicity of MAO metablites of catecholamine neurotransmitters:role in neurodegenerative diseases[J].Neurotoxicology,2004,25:101-115.
  • 10Sherer TB,Kim JH,Betarbet R,et al.Subcutaneous rotenone exposure causes highly selective dopaminergic degeneration and alpha-synuclein aggregation[J].Exp Neurol,2003,179(1):9-16.

共引文献5

同被引文献28

  • 1郭燕婷,李艳梅,赵玉芬.脂蛋白合成新进展[J].有机化学,2004,24(7):722-727. 被引量：5
  • 2JingLIU AnningLIN.Role of JNK activation in apoptosis:Adouble-edged sword[J].Cell Research,2005,15(1):36-42. 被引量：76
  • 3刘世荣,何维.SUMO化修饰:一种多功能的蛋白质翻译后修饰方式[J].医学分子生物学杂志,2006,3(3):212-215. 被引量：9
  • 4Blom N,Sicheritz-Pontan T, Gupta R, et al. Prediction of post-translational glycosylation and phosphorylation of proteins from the amino acid sequence. Proteomics,2004 (4) : 1633-1649.
  • 5Hart GW. Dynamic O-linked glycosylation of nuclear and cytoskeletal proteins. Annu Rev Biochem, 1997,66:315-335.
  • 6Gavel Y,von Heijne G. Statistical studies of N-glycosylated proteins have indicated that the frequency of nonglycosylated Asn-Xaa-(Thr/ Ser) sequons increases toward the C terminus. Protein Eng, 1990,3: 433 -442.
  • 7Taylor MT, Drickamer K. Introduction to Glycobiology [ M ]. Oxford : Oxford University Press,2002.
  • 8Hitchen PG, Dell A. Bacterial glycoproteomics. Microbiology,2006, 152 ( Pt6 ) : 1575-1580.
  • 9Walia H, Chen HY,Sun JM,et al. Histone acetylation is required to maintain the unfolded nucleosome structure associated with transcribing DNA. J Biol Chem, 1998,17:2865-2876.
  • 10Gray MW, Burger G, Lang BF. Mitochondrial evolution. Science, 1999,283 (5407) : 1476-148.

引证文献2

二级引证文献10

激光杂志
2010年 第4期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部